AtriCure (ATRC) EV to EBITDA (2010 - 2026)

AtriCure (ATRC) has reported EV to EBITDA for 17 consecutive years, with 129.89 the latest figure, recorded in Q2 2026.

• On a quarterly basis, EV to EBITDA rose 153.24% year-over-year to 129.89 in Q2 2026; TTM through Jun 2026 was 97.39, a 319.68% increase from a year earlier, with the FY2025 full-year figure at 190.78, down 456.93% from the prior year.
• EV to EBITDA was 129.89 for Q2 2026 at AtriCure, down from 2468.48 in the prior quarter.
• Over five years, EV to EBITDA peaked at 7714.03 in Q3 2025 and troughed at 533.37 in Q2 2023.
• A 5-year average of 432.31 and a median of 162.45 in 2022 frame the typical range for EV to EBITDA.
• Across the five-year window, EV to EBITDA plunged 606.71% in 2022 and surged 4719.46% in 2025, its largest moves.
• Over 5 years, EV to EBITDA stood at 470.35 in 2022, then jumped by 61.76% to 179.85 in 2023, then surged by 47.52% to 94.38 in 2024, then jumped by 866.61% to 723.54 in 2025, then tumbled by 82.05% to 129.89 in 2026.
• The last three EV to EBITDA figures came in at 129.89 (Q2 2026), 2468.48 (Q1 2026), and 723.54 (Q4 2025), per Business Quant data.